Income Tax Expense (Benefit) of Medtronic plc from 26 Apr 2013 to 23 Jan 2026

Taxonomy & unit: us-gaap: USD
Description: Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary: Medtronic plc quarterly and annual Income Tax Expense (Benefit) in USD history and change rate from 26 Apr 2013 to 23 Jan 2026.
Medtronic plc Income Tax Expense (Benefit) for the quarter ending 23 Jan 2026 was $254,000,000, a 7.2% increase year-over-year.
Medtronic plc Income Tax Expense (Benefit) for the twelve months ending 23 Jan 2026 was $922,000,000, a 1.3% decline year-over-year.
Medtronic plc annual Income Tax Expense (Benefit) for 2024 was $936,000,000, a 17% decline from 2023.
Medtronic plc annual Income Tax Expense (Benefit) for 2023 was $1,133,000,000, a 28% decline from 2022.
Medtronic plc annual Income Tax Expense (Benefit) for 2022 was $1,580,000,000, a 246% increase from 2021.
Source SEC data: View on sec.gov

Income Tax Expense (Benefit), Trailing 12 Months (USD)

Income Tax Expense (Benefit), Quarterly (USD)

Income Tax Expense (Benefit), YoY Quarterly Change (%)

Income Tax Expense (Benefit), Annual (USD)

Income Tax Expense (Benefit), YoY Annual Change (%)

Medtronic plc Quarterly Income Tax Expense (Benefit) (USD)

Period	TTM Value	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed	Fiscal Year	Fiscal Period
Q4 2025	$922,000,000	$254,000,000	+$17,000,000	+7.2%	25 Oct 2025	23 Jan 2026	10-Q	24 Feb 2026	2026	Q3
Q3 2025	$905,000,000	$215,000,000	-$66,000,000	-23%	26 Jul 2025	24 Oct 2025	10-Q	25 Nov 2025	2026	Q2
Q2 2025	$971,000,000	$255,000,000	+$35,000,000	+16%	26 Apr 2025	25 Jul 2025	10-Q	26 Aug 2025	2026	Q1
Q1 2025	$936,000,000	$198,000,000	+$2,000,000	+1%	25 Jan 2025	25 Apr 2025	10-K	20 Jun 2025	2025	FY
Q4 2024	$934,000,000	$237,000,000	+$102,000,000	+76%	26 Oct 2024	24 Jan 2025	10-Q	24 Feb 2026	2026	Q3
Q3 2024	$832,000,000	$281,000,000	-$121,000,000	-30%	27 Jul 2024	25 Oct 2024	10-Q	25 Nov 2025	2026	Q2
Q2 2024	$953,000,000	$220,000,000	-$180,000,000	-45%	27 Apr 2024	26 Jul 2024	10-Q	26 Aug 2025	2026	Q1
Q1 2024	$1,133,000,000	$196,000,000	-$167,000,000	-46%	27 Jan 2024	26 Apr 2024	10-K	20 Jun 2025	2025	FY
Q4 2023	$1,300,000,000	$135,000,000	-$11,000,000	-7.5%	28 Oct 2023	26 Jan 2024	10-Q	25 Feb 2025	2025	Q3
Q3 2023	$1,311,000,000	$402,000,000	-$557,000,000	-58%	29 Jul 2023	27 Oct 2023	10-Q	26 Nov 2024	2025	Q2
Q2 2023	$1,868,000,000	$400,000,000	+$288,000,000	+257%	29 Apr 2023	28 Jul 2023	10-Q	27 Aug 2024	2025	Q1
Q1 2023	$1,580,000,000	$363,000,000	+$253,000,000	+230%	28 Jan 2023	28 Apr 2023	10-K	20 Jun 2025	2025	FY
Q4 2022	$1,327,000,000	$146,000,000	+$40,000,000	+38%	29 Oct 2022	27 Jan 2023	10-Q	27 Feb 2024	2024	Q3
Q3 2022	$1,287,000,000	$959,000,000	+$783,000,000	+445%	30 Jul 2022	28 Oct 2022	10-Q	30 Nov 2023	2024	Q2
Q2 2022	$504,000,000	$112,000,000	+$48,000,000	+75%	30 Apr 2022	29 Jul 2022	10-Q	31 Aug 2023	2024	Q1
Q1 2022	$456,000,000	$110,000,000	-$90,000,000	-45%	29 Jan 2022	29 Apr 2022	10-K	20 Jun 2024	2024	FY
Q4 2021	$546,000,000	$106,000,000	+$165,000,000		30 Oct 2021	28 Jan 2022	10-Q	01 Mar 2023	2023	Q3
Q3 2021	$381,000,000	$176,000,000	+$145,000,000	+468%	31 Jul 2021	29 Oct 2021	10-Q	01 Dec 2022	2023	Q2
Q2 2021	$236,000,000	$64,000,000	-$29,000,000	-31%	01 May 2021	30 Jul 2021	10-Q	01 Sep 2022	2023	Q1
Q1 2021	$265,000,000	$200,000,000	+$634,000,000		30 Jan 2021	30 Apr 2021	10-K	22 Jun 2023	2023	FY
Q4 2020	$369,000,000	$59,000,000	+$281,000,000	+83%	31 Oct 2020	29 Jan 2021	10-Q	03 Mar 2022	2022	Q3
Q3 2020	$650,000,000	$31,000,000	+$108,000,000		01 Aug 2020	30 Oct 2020	10-Q	02 Dec 2021	2022	Q2
Q2 2020	$758,000,000	$93,000,000	-$7,000,000	-7%	25 Apr 2020	31 Jul 2020	10-Q	02 Sep 2021	2022	Q1
Q1 2020	$751,000,000	$434,000,000	-$544,000,000	-495%	25 Jan 2020	24 Apr 2020	10-K	23 Jun 2022	2022	FY
Q4 2019	$207,000,000	$340,000,000	-$439,000,000	-443%	26 Oct 2019	24 Jan 2020	10-Q	05 Mar 2021	2021	Q3
Q3 2019	$232,000,000	$77,000,000	-$312,000,000	-133%	27 Jul 2019	25 Oct 2019	10-Q	03 Dec 2020	2021	Q2
Q2 2019	$544,000,000	$100,000,000	-$3,000,000	-2.9%	27 Apr 2019	26 Jul 2019	10-Q	03 Sep 2020	2021	Q1
Q1 2019	$547,000,000	$110,000,000	-$150,000,000	-58%	26 Jan 2019	26 Apr 2019	10-K	25 Jun 2021	2021	FY
Q4 2018	$697,000,000	$99,000,000	-$2,320,000,000	-96%	27 Oct 2018	25 Jan 2019	10-Q	28 Feb 2020	2020	Q3
Q3 2018	$3,017,000,000	$235,000,000	+$520,000,000		28 Jul 2018	26 Oct 2018	10-Q	03 Dec 2019	2020	Q2
Q2 2018	$2,497,000,000	$103,000,000	-$83,000,000	-45%	28 Apr 2018	27 Jul 2018	10-Q	30 Aug 2019	2020	Q1
Q1 2018	$2,580,000,000	$260,000,000	-$11,000,000	-4.1%	27 Jan 2018	27 Apr 2018	10-K	19 Jun 2020	2020	FY
Q4 2017	$2,591,000,000	$2,419,000,000	+$2,272,000,000	+1546%	28 Oct 2017	26 Jan 2018	10-Q	01 Mar 2019	2019	Q3
Q3 2017	$319,000,000	$285,000,000	-$386,000,000	-382%	29 Jul 2017	27 Oct 2017	10-Q	29 Nov 2018	2019	Q2
Q2 2017	$705,000,000	$186,000,000	+$127,000,000	+215%	29 Apr 2017	28 Jul 2017	10-Q	31 Aug 2018	2019	Q1
Q1 2017	$578,000,000	$271,000,000	+$240,000,000	+774%	28 Jan 2017	28 Apr 2017	10-K	21 Jun 2019	2019	FY
Q4 2016	$338,000,000	$147,000,000	+$63,000,000	+75%	29 Oct 2016	27 Jan 2017	10-Q	02 Mar 2018	2018	Q3
Q3 2016	$275,000,000	$101,000,000	-$462,000,000	-82%	30 Jul 2016	28 Oct 2016	10-Q	04 Dec 2017	2018	Q2
Q2 2016	$737,000,000	$59,000,000	-$61,000,000	-51%	30 Apr 2016	29 Jul 2016	10-Q	01 Sep 2017	2018	Q1
Q1 2016	$798,000,000	$31,000,000	-$157,000,000	-84%	30 Jan 2016	29 Apr 2016	10-K	22 Jun 2018	2018	FY
Q4 2015	$955,000,000	$84,000,000	-$133,000,000	-61%	31 Oct 2015	29 Jan 2016	10-Q	03 Mar 2017	2017	Q3
Q3 2015	$1,088,000,000	$563,000,000	+$369,000,000	+190%	01 Aug 2015	30 Oct 2015	10-Q	05 Dec 2016	2017	Q2
Q2 2015	$719,000,000	$120,000,000	-$92,000,000	-43%	25 Apr 2015	31 Jul 2015	10-Q	07 Sep 2016	2017	Q1
Q1 2015	$811,000,000	$188,000,000			24 Jan 2015	24 Apr 2015	10-K	27 Jun 2017	2017	FY
Q4 2014		$217,000,000			25 Oct 2014	23 Jan 2015	10-Q	09 Mar 2016	2016	Q3
Q3 2014		$194,000,000			26 Jul 2014	24 Oct 2014	10-Q	09 Dec 2015	2016	Q2
Q2 2014		$212,000,000			26 Apr 2014	25 Jul 2014	10-Q	09 Sep 2015	2016	Q1

Medtronic plc Annual Income Tax Expense (Benefit) (USD)

Period	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed	Fiscal Year	Fiscal Period
2024	$936,000,000	-$197,000,000	-17%	27 Apr 2024	25 Apr 2025	10-K	20 Jun 2025	2025	FY
2023	$1,133,000,000	-$447,000,000	-28%	29 Apr 2023	26 Apr 2024	10-K	20 Jun 2025	2025	FY
2022	$1,580,000,000	+$1,124,000,000	+246%	30 Apr 2022	28 Apr 2023	10-K	20 Jun 2025	2025	FY
2021	$456,000,000	+$191,000,000	+72%	01 May 2021	29 Apr 2022	10-K	20 Jun 2024	2024	FY
2020	$265,000,000	+$1,016,000,000		25 Apr 2020	30 Apr 2021	10-K	22 Jun 2023	2023	FY
2019	$751,000,000	-$1,298,000,000	-237%	27 Apr 2019	24 Apr 2020	10-K	23 Jun 2022	2022	FY
2018	$547,000,000	-$2,033,000,000	-79%	28 Apr 2018	26 Apr 2019	10-K	25 Jun 2021	2021	FY
2017	$2,580,000,000	+$2,002,000,000	+346%	29 Apr 2017	27 Apr 2018	10-K	19 Jun 2020	2020	FY
2016	$578,000,000	-$220,000,000	-28%	30 Apr 2016	28 Apr 2017	10-K	21 Jun 2019	2019	FY
2015	$798,000,000	-$13,000,000	-1.6%	25 Apr 2015	29 Apr 2016	10-K	22 Jun 2018	2018	FY
2014	$811,000,000	+$171,000,000	+27%	26 Apr 2014	24 Apr 2015	10-K	27 Jun 2017	2017	FY
2013	$640,000,000	-$144,000,000	-18%	27 Apr 2013	25 Apr 2014	10-K	28 Jun 2016	2016	FY
2012	$784,000,000			28 Apr 2012	26 Apr 2013	10-K	23 Jun 2015	2015	FY

* An asterisk sign (*) next to the value indicates that the value is likely invalid.